Prostate Vanguard E003: Useful Imaging
IS IT POSSIBLE TO SKIP A BIOPSY? We’ve been talking a lot about the different types of biopsies – targeted vs random and all these new developments. But what’s really …
Prostate Vanguard E002: No More Random Biopsies
NO MORE RANDOM BIOPSIES. Over a million men get a prostate biopsy every year and quite often, in fact almost always, they are unaware of how dangerous a biopsy can …
Prostate Vanguard E001: Why Prostate Imaging?
Why do we have scans all of a sudden as of 2013 for prostate cancer? We’ve had mammograms for years, we’ve had chest CTs for lung cancer – the problem …
What is a Prostate Vanguard?
Prostate Oncology Specialists in Marina del Rey, CA is leading a movement to help men learn that they have options for their prostate cancer — Dr. Mark Scholz discusses this …
Is It Possible to Substitute a Scan for Prostate Biopsy?
BY MARK SCHOLZ, MD There are two different ways to do a prostate biopsy – targeted and random. The random 12-core prostate biopsy is standard and has been in use for over …
Elevated PSA From Screening: What to Do?
BY MARK SCHOLZ, MD The PSA assay, along with cholesterol and other tests, is a common component of the blood testing that occurs during a man’s annual physical examination. But …
Selecting the Best Therapy for Newly-Diagnosed Prostate Cancer
BY MARK SCHOLZ, MD Due to the absence of well-designed comparative studies, treatment selection for prostate cancer has been highly controversial. However, in October 2016, two landmark articles published in the New England …
Choosing the Best Prostate Cancer Treatment for You
By Micah Chancey & Mark Scholz, MD Surgery, Radiation, Active Surveillance, or Seed Implant? Since there are three different risk categories of newly-diagnosed prostate cancer—low, intermediate and high—optimal treatment varies. READ THE FULL …
Is the Twelve Core Random Biopsy for Prostate Cancer Obsolete?
BY MARK SCHOLZ, MD A perfect test for prostate cancer should detect high-grade prostate cancer accurately while avoiding the over-diagnosis of harmless, low-grade cancers (the Gleason 6 variety). Back in 2011, the US Preventative Services …
PSA Screening for Prostate Cancer, Not for the Ill-Informed
BY MARK SCHOLZ, MD There is a real danger that PSA screening will lead to overtreatment. The government, having studied this situation, has therefore recommended dropping PSA screening altogether. This proposal doesn’t …